U.S. Retail REITs Stock News

Trade Desk (TTD) is back in focus after announcing new integrations with Pacvue and Skai, as well as a global partnership with DramaBox, while a large shareholder trimmed its position ahead of the upcoming earnings report. See our latest analysis for Trade Desk. The recent integrations with Pacvue, Skai, and DramaBox come after a period where Trade Desk’s 30 day share price return of 9.93% contrasts with a 1 year total shareholder return of a 55.19% decline. This suggests short term momentum...

American Airlines Group recently priced US$1.14 billion in enhanced equipment trust certificates to help finance 32 new and existing aircraft as it continues its fleet modernization program amid higher fuel costs and geopolitical tensions. This financing, alongside proposed governance changes and ongoing shareholder activism ahead of the June 10, 2026 annual meeting, highlights how American is balancing capital needs, board structure, and investor influence at a time of elevated expenses and...

PAMT (PAMT) has just opened Q1 2026 with a trailing twelve month revenue base of about US$598.1 million and a basic EPS loss of US$2.48 per share, setting the stage for another result where the top line is sizeable but profitability remains under pressure. Over recent quarters the company has seen quarterly revenue move from US$182.6 million in Q3 2024 to US$141.3 million in Q4 2025, while quarterly basic EPS shifted from a profit of US$0.11 to a loss of US$1.40. The latest update therefore...

Ingram Micro Holding Corporation has already reported first-quarter 2026 results, with net sales rising to US$13.96 billion and net income to US$98.87 million, alongside higher earnings per share and an increased quarterly dividend of US$0.084 per share. The quarter also underscored how large GPU and AI infrastructure deals, enabled by the Xvantage digital platform, are reshaping the mix of revenue growth and profitability across Ingram Micro’s global operations. With Q1 results boosted by...

ImmunityBio (IBRX) is back on investor radars after reporting a 168% year over year increase in quarterly product revenue, driven by ANKTIVA’s commercial rollout across the US, Europe, Macau, and Saudi Arabia. See our latest analysis for ImmunityBio. Despite the strong ANKTIVA rollout, ImmunityBio’s recent share price return has cooled, with a 7 day share price return of a 4.4% decline and a 30 day share price return of a 2.6% decline. However, the year to date share price return of 252% and...

In the first quarter of 2026, General Electric reported revenue of US$12,392 million, slightly lower net income of US$1,904 million, steady earnings per share, and continued its multi-year US$14.46 billion share repurchase program while securing a US$107.8 million U.S. defense engine contract. Beyond the headline numbers, the combination of expanding aerospace defense work and disciplined capital returns through buybacks highlights how GE is reinforcing its focus as a pure-play aerospace...

Moderna (MRNA) opened 2026 with Q1 results that continue the recent trend of revenue and losses sitting side by side, with trailing 12 month revenue at US$1.9 billion and a basic EPS loss of US$7.25 per share tied to a net loss of US$2.8 billion. Over recent quarters, the company has seen quarterly revenue move between US$108 million and US$1.9 billion with basic EPS ranging from a small profit of US$0.03 per share in Q3 2024 to losses of more than US$2.50 per share in several 2025 quarters,...

In late April 2026, Sunrun announced it had priced a US$584 million securitization of residential solar leases and power purchase agreements, its sixteenth such transaction since 2015, featuring US$584 million of A-rated notes with a 6.30% coupon and improved credit spreads versus its 2025 deals. This financing, backed by nearly 38,706 systems across 19 states, Washington D.C. and Puerto Rico with a weighted average customer FICO of 744, underscores Sunrun’s continued access to large-scale,...

Vanguard Capital Management has disclosed a 7.3% stake in Cencora (NYSE:COR) via a Schedule 13G filing. The filing identifies Vanguard as one of Cencora’s largest institutional holders and classifies the position as being held for investment purposes. Cencora operates as a major player in pharmaceutical distribution and related healthcare services, sitting at the center of drug supply chains that connect manufacturers, pharmacies, and providers. With its scale and logistics capabilities,...

If you are wondering whether CRH at around US$115 a share still offers value, or if most of the easy gains are already behind it, this article focuses squarely on what the current price might mean for you. The stock has delivered a 10.3% return over the past 30 days and 18.4% over the last year, while also showing a 2.2% decline over the past week and an 8.7% decline year to date. Recent headlines around CRH have focused on its position as a major player in construction materials and on how...

If you are wondering whether Snap at around US$6.29 is a bargain or a value trap, the key is understanding what the current price actually reflects about its future. The share price has moved sharply in the short term, with returns of 11.3% over the last 7 days and 35.9% over the last 30 days, set against a year to date return of negative 22.6% and a 1 year return of negative 25.6%. These moves come as Snap continues to sit in the spotlight of investors who are weighing its long term...

Xylem Inc. recently reported past first-quarter 2026 results, with revenue rising to US$2.13 billion and net income reaching US$193 million, lifting earnings per share from continuing operations to US$0.79. The company also raised its full-year 2026 revenue outlook, authorized a new US$1.50 billion share repurchase program, and advanced growth in water quality and long-term service contracts. Next, we’ll examine how the raised full-year revenue guidance shapes Xylem’s existing investment...

Why Integer Holdings is on investors’ radar today Integer Holdings (ITGR) recently drew attention after a period where the share price showed negative returns over the past year, despite revenue of about US$1.86b and net income of roughly US$141.8m. See our latest analysis for Integer Holdings. At a share price of US$84.03, Integer Holdings has seen short term pressure, with a 1 day share price return decline of 5.06% and a 1 year total shareholder return decline of 33.13%. This suggests...

In late April 2026, Park Hotels & Resorts Inc. reported first quarter 2026 results showing revenue of US$622 million and a swing to net income of US$11 million, alongside funds from operations per share of US$0.45 that exceeded analyst expectations and an affirmed quarterly dividend of US$0.25 per share. The company also modestly trimmed full-year net income guidance while raising RevPAR and profitability outlooks, underscoring how renovation-driven performance, non-core hotel sales, and a...

Millicom International Cellular: recent performance snapshot Millicom International Cellular (TIGO) has drawn attention after a recent share price move, with the stock closing at US$84.32. That level sits alongside a reported US$14.1b market value and a value score of 5. See our latest analysis for Millicom International Cellular. While the 1-day share price return of -0.66% was negative, Millicom International Cellular’s 30-day share price return of 5.88% and year to date share price return...

In late April 2026, SEI and Carlyle Group announced an enhanced partnership to broaden access to institutional-grade private market investments across wealth and retirement channels, including new model portfolios and defined contribution solutions. This move extends their long-running fund administration and technology relationship into product design and distribution, potentially making private markets more accessible for individual retirement and wealth investors. We’ll now consider how...

Enterprise Financial Services (EFSC) drew fresh attention after reporting first quarter 2026 results, with net interest income of US$166.15 million, net income of US$49.36 million, and a quarterly common dividend set at US$0.34 per share. See our latest analysis for Enterprise Financial Services. The first quarter earnings, ongoing share repurchases totaling 3.68% of shares since 2022, and the latest common and preferred dividend declarations have come alongside an 8.95% year to date share...

Booking Holdings (BKNG) is back in focus after first quarter 2026 earnings showed revenue of US$5,532 million and net income of US$1,083 million, alongside a 25-for-1 stock split and refreshed guidance. See our latest analysis for Booking Holdings. Despite the strong first quarter results, the share price has been under pressure, with a 1-day share price return of 0.75% contrasting with a year to date share price return showing a decline of 20.33%. However, the 5 year total shareholder return...

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...

If you are wondering whether Tractor Supply's share price now reflects fair value or an opportunity, starting with a clear look at valuation can help frame your next move. The stock last closed at US$33.83, and recent returns have been weak, with a 7.9% decline over 7 days, 22.8% over 30 days, and 33.4% year to date, along with a 32.3% drop over 1 year. These moves have kept Tractor Supply on many investors' watchlists, as they reassess what the current price says about expectations and...

Zoetis recently expanded the capabilities of its AI-powered Vetscan OptiCell hematology analyzer, while investors and analysts have turned their attention to its upcoming May 7 earnings release and evolving product portfolio. The combination of point-of-care diagnostics innovation and heightened expectations around earnings and companion animal growth is sharpening focus on how Zoetis’ business mix may be evolving. We’ll now examine how the Vetscan OptiCell upgrade could influence Zoetis’...

In late April 2026, Pfizer resolved US patent disputes over its cardiomyopathy drug VYNDAMAX by settling with three generic manufacturers, effectively extending its market exclusivity until June 1, 2031 and consolidating the brand’s position after discontinuing VYNDAQEL in the United States. This legal outcome gives Pfizer clearer medium-term visibility on a key revenue stream in transthyretin-mediated amyloidosis, at the same time as its oncology portfolio advances with positive Phase 3...

In late April 2026, Boeing and several airline customers announced major deals, including Biman Bangladesh Airlines’ largest-ever order for 14 787 Dreamliner and 737 MAX jets, alongside significant new 737 MAX commitments from Copa Airlines and SCAT Airlines, while Boeing also reported first-quarter revenue of US$22,217 million with a net loss of US$4 million. These wins, combined with Boeing’s record-high US$695.00 billion backlog and progress on programs such as the MQ-25A Stingray and...

MSCI Inc. reported first-quarter 2026 results showing sales of US$850.8 million and net income of US$406.0 million, with basic earnings per share from continuing operations of US$5.54, while also completing US$1.35 billion of buybacks under its program announced in October 2025 and affirming a quarterly dividend of US$2.05 per share. These results highlight the earnings impact of higher subscription and asset-based fee revenues, alongside continued capital returns through share repurchases...